Literature DB >> 18368506

Antioxidant and protective effects of silymarin on ischemia and reperfusion injury in the kidney tissues of rats.

Faruk Turgut1, Omer Bayrak, Ferhat Catal, Reyhan Bayrak, Ali Fuat Atmaca, Akif Koc, Ali Akbas, Ali Akcay, Dogan Unal.   

Abstract

BACKGROUND: Renal ischemia/reperfusion (I/R) injury is a major cause of acute renal failure. Silymarin is extracted from Silybum marianum and Cynara cardunculus seeds and fruits. The aim of this study is to investigate whether silymarin administration prevents the damage induced by I/R in rat kidneys.
MATERIALS AND METHODS: Thirty male Wistar rats were randomly divided into five experimental groups (n = 6, each) as follows; control group, sham-operated group, I/R group, silymarin group, and I/R + silymarin group. In the I/R and I/R + silymarin groups, both renal arteries were occluded using nontraumatic microvascular clamps for 45 min. Then, at the end of 24 h of reperfusion, the animals were killed. Kidney function tests, the serum and tissue antioxidant enzymes and oxidant products were determined.
RESULTS: Animals that were subjected to I/R exhibited significant increase in serum urea, creatinine, and cystatin C levels compared with the rats treated with silymarin prior to the I/R process (P < 0.001). The serum enzymatic activities of superoxide dismutase and glutathione peroxidase significantly decreased in the I/R group; however, this reduction was significantly improved by the treatment with silymarin (P < 0.001 and P < 0.05, respectively). Renal I/R produced a significant increase in serum and tissue malondialdehyde, nitric oxide, and protein carbonyl as compared with controls. Treatment with silymarin resulted in significant reduction in these markers (P < 0.001).
CONCLUSION: Based on our findings, silymarin protects the kidneys against I/R injury. This finding may provide a basis for the development of novel therapeutic strategies for protection against the damages caused by I/R.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18368506     DOI: 10.1007/s11255-008-9365-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  27 in total

1.  Protection against liver ischemia-reperfusion injury in rats by silymarin or verapamil.

Authors:  C P Oliveira; F P Lopasso; F R Laurindo; R M Leitão; A A Laudanna
Journal:  Transplant Proc       Date:  2001-09       Impact factor: 1.066

2.  The rise of prevalence and the fall of mortality of patients with acute renal failure: what the analysis of two databases does and does not tell us.

Authors:  Norbert Lameire; Wim Van Biesen; Raymond Vanholder
Journal:  J Am Soc Nephrol       Date:  2006-03-15       Impact factor: 10.121

3.  A new automated colorimetric method for measuring total oxidant status.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2005-10-07       Impact factor: 3.281

4.  A simple method for clinical assay of superoxide dismutase.

Authors:  Y Sun; L W Oberley; Y Li
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

5.  Oxidative and nitrosative stress in acute renal ischemia.

Authors:  E Noiri; A Nakao; K Uchida; H Tsukahara; M Ohno; T Fujita; S Brodsky; M S Goligorsky
Journal:  Am J Physiol Renal Physiol       Date:  2001-11

6.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

Authors:  D E Paglia; W N Valentine
Journal:  J Lab Clin Med       Date:  1967-07

7.  Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method.

Authors:  N K Cortas; N W Wakid
Journal:  Clin Chem       Date:  1990-08       Impact factor: 8.327

8.  Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas.

Authors:  Claudia Soto; Rosa Recoba; Héctor Barrón; Carlos Alvarez; Liliana Favari
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2003-11       Impact factor: 3.228

9.  Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.

Authors:  Adam Gordon; Daryl A Hobbs; D Scott Bowden; Michael J Bailey; Joanne Mitchell; Andrew J P Francis; Stuart K Roberts
Journal:  J Gastroenterol Hepatol       Date:  2006-01       Impact factor: 4.029

Review 10.  Chemopreventive efficacy of silymarin in skin and prostate cancer.

Authors:  Gagan Deep; Rajesh Agarwal
Journal:  Integr Cancer Ther       Date:  2007-06       Impact factor: 3.279

View more
  19 in total

1.  Effect of silymarin in the prevention of Cisplatin nephrotoxicity, a clinical trial study.

Authors:  Ali Momeni; Ali Hajigholami; Shohreh Geshnizjani; Soleiman Kheiri
Journal:  J Clin Diagn Res       Date:  2015-04-01

Review 2.  Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.

Authors:  Tomas Koltai; Larry Fliegel
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

3.  Modulatory effect of silymarin on pulmonary vascular dysfunction through HIF-1α-iNOS following rat lung ischemia-reperfusion injury.

Authors:  Yanwu Jin; Xin Zhao; He Zhang; Qingsong Li; Guodong Lu; Xiaogang Zhao
Journal:  Exp Ther Med       Date:  2016-05-19       Impact factor: 2.447

Review 4.  Acute kidney injury in the elderly population.

Authors:  Rahmi Yilmaz; Yunus Erdem
Journal:  Int Urol Nephrol       Date:  2009-08-26       Impact factor: 2.370

5.  The Protective Role of Gallic Acid Pretreatment On Renal Ischemia-reperfusion Injury in Rats.

Authors:  Hassan Ahmadvand; Banafsheh Yalameha; Glavizh Adibhesami; Maryam Nasri; Negar Naderi; Esmaeel Babaeenezhad; Negar Nouryazdan
Journal:  Rep Biochem Mol Biol       Date:  2019-04

6.  Protective Role of Silymarin and Deferoxamine Against Iron Dextran-induced Renal Iron Deposition in Male Rats.

Authors:  Mehdi Nematbakhsh; Zahra Pezeshki; Behjat Alsaadat Moaeidi; Fatemeh Eshraghi-Jazi; Ardeshir Talebi; Hamid Nasri; Shahrzad Baradaran; Marjan Gharagozloo; Tahereh Safari; Maryam Haghighi
Journal:  Int J Prev Med       Date:  2013-03

7.  Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats.

Authors:  Marina Gabriela Monteiro Carvalho Mori da Cunha; Silvia Zia; Fanny Oliveira Arcolino; Marianne Sylvia Carlon; Diego Vilibaldo Beckmann; Ney Luis Pippi; Dominguita Luhers Graça; Elena Levtchenko; Jan Deprest; Jaan Toelen
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

8.  Protective role of silymarin in a mouse model of renal Ischemia-Reperfusion injury.

Authors:  Jian Tan; Jianpeng Hu; Yonghui He; Feilun Cui
Journal:  Diagn Pathol       Date:  2015-10-31       Impact factor: 2.644

9.  Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model.

Authors:  Mitra Navidi-Shishaone; Soheila Mohhebi; Mehdi Nematbakhsh; Shahla Roozbehani; Ardeshir Talebi; Zahra Pezeshki; Fatemeh Eshraghi-Jazi; Safoora Mazaheri; Sohiela Shirdavani; Marjan Gharagozloo; Behjat Alsaadat Moaeidi
Journal:  Int J Prev Med       Date:  2014-01

10.  Silymarin attenuates mycophenolate mofetil-induced duodenal disorders in rats.

Authors:  Hassan Malekinejad; Sanaz Sheikhzadeh; Rahim Hobbenaghi
Journal:  Avicenna J Phytomed       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.